A Bioethics Conversation: What’s Next for Psychedelics?

The webinar will bring together panelists to reflect on the current legal and regulatory environment, the state of psychedelic research, and psychedelic use within and outside of healthcare settings. Panelists will explore a range of ethical issues, including equitable access, informed consent, evidentiary standards, and the responsible integration of psychedelic therapies into clinical care.

Panelists I. Glenn Cohen, JD; Amy Lynn McGuire, JD, PhD; and David B. Yaden, PhD will share their insights on this important and timely topic. For more information about the webinar and panelists, visit our blog.

After the panelists present opening remarks, the webinar will shift to a moderated panel discussion, with audience questions welcomed.